Overview

A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Status:
Terminated
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
It is thought that Edratide may be able to reduce the symptoms of SLE.
Phase:
Phase 2
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Pharmaceutical Industries